Related references
Note: Only part of the references are listed.Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses
Robert L. Coleman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital
Nisa Prueksaritanond et al.
Asian Pacific Journal of Cancer Prevention (2016)
Diagnostic accuracy of cancer antigen 125 forendometriosis: a systematic review and meta-analysis
M. Hirsch et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)
Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer
Pinar Kemik et al.
GYNECOLOGIC ONCOLOGY (2016)
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer Diagnosis, Treatment and Follow-up
Nicoletta Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Recommendations for description and validation of antibodies for research use
Tea Lanisnik Rizner et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
IS THERE A REPRODUCIBILITY CRISIS?
Monya Baker
NATURE (2016)
The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review
Argiri Sianou et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Prognostic value of preoperative Ca125 and Tag72 serum levels and their correlation to disease relapse and survival in endometrial cancer
Eva Myriokefalitaki et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis
Tolgay Tuyan Ilhan et al.
Asian Pacific Journal of Cancer Prevention (2015)
Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
Donal J. Brennan et al.
BMC CANCER (2015)
Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
Tao Jiang et al.
BMC CANCER (2015)
Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging
Lubos Minar et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs
Eric Londin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer
Jianpei Li et al.
PLOS ONE (2015)
USA Endometrial Cancer Projections to 2030: should we be concerned?
M. Aamir Sheikh et al.
FUTURE ONCOLOGY (2014)
Serum HE4 as a prognostic marker in endometrial cancer - A population based study
Donal. J. Brennan et al.
GYNECOLOGIC ONCOLOGY (2014)
Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker
Yutaka Ihata et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2014)
Editorial: Antibody Can Get It Right: Confronting Problems of Antibody Specificity and Irreproducibility
Agnes Schonbrunn
MOLECULAR ENDOCRINOLOGY (2014)
Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
Lin Wang et al.
PLOS ONE (2014)
Updates in diagnostic immunohistochemistry in endometrial carcinoma
Sarah Chiang et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2014)
Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis
Yachun Bie et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
PITFALLS AND LIMITATIONS IN TRANSLATION FROM BIOMARKER DISCOVERY TO CLINICAL UTILITY IN PREDICTIVE AND PERSONALISED MEDICINE
Elisabeth Drucker et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
Sofie L. Antonsen et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2013)
The diagnostic and prognostic value of serum YKL-40 in endometrial cancer
Jiang-tao Fan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Sperm-Associated Antigen 9 is a Promising marker for Early Diagnosis of Endometrial Cancer
Eralp Baser et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Editorial: Antibody Validation Requirements for Articles Published in Endocrinology
Andrea C. Gore
ENDOCRINOLOGY (2013)
The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer
Veronika Seebacher et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer
Angel Chao et al.
GYNECOLOGIC ONCOLOGY (2013)
Visfatin, a potential biomarker and prognostic factor for endometrial cancer
Wenyan Tian et al.
GYNECOLOGIC ONCOLOGY (2013)
Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients
Anna Torres et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
MicroRNAs in endometrial cancer
Kouji Banno et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer
Tea Lanišnik Rižner
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Translational biomarker discovery in clinical metabolomics: an introductory tutorial
Jianguo Xia et al.
METABOLOMICS (2013)
Endometrial carcinoma: molecular alterations involved in tumor development and progression
A. Yeramian et al.
ONCOGENE (2013)
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
Roberto Angioli et al.
TUMOR BIOLOGY (2013)
The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients
Beyhan Omer et al.
TUMOR BIOLOGY (2013)
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
Elisabeth Drucker et al.
EPMA JOURNAL (2013)
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
Anna Torres et al.
BMC CANCER (2012)
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial
V. Seebacher et al.
BRITISH JOURNAL OF CANCER (2012)
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
Laura Zanotti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Role of microRNAs in Gynecological Pathology
J. Gilabert-Estelles et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Hematopoietic cytokines as tumor markers in gynecological malignancies: A multivariate analysis with ROC curve in endometrial cancer patients
Slawomir Lawicki et al.
GROWTH FACTORS (2012)
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
Eleftheria Kalogera et al.
GYNECOLOGIC ONCOLOGY (2012)
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie et al.
GYNECOLOGIC ONCOLOGY (2012)
The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
James Nicklin et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte
Bo Wook Kim et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Nils Bolstad et al.
TUMOR BIOLOGY (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Clinical evaluation of women with PMB. Is it always necessary an endometrial biopsy to be performed? A review of the literature
Marina Dimitraki et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2011)
Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer
Yu-Li Chen et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2011)
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E. Bignotti et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
Anne Cathrine Staff et al.
CLINICAL CANCER RESEARCH (2011)
Altered Metabolism and Newborn Screening Using Tandem Mass Spectrometry: Lessons Learned from the Bench to Bedside
> H. Chace et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer
Bozena Dobrzycka et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
Relevance of gamma-glutamyltransferase - a marker for apoptotic balance - in predicting tumor stage and prognosis in cervical cancer
Stephan Polterauer et al.
GYNECOLOGIC ONCOLOGY (2011)
Prediction of endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness ≥ 4.5 mm
G. Opolskiene et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2011)
Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer
Seung-Su Han et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
Validation of serum biomarkers for detection of early- and late-stage endometrial cancer
Gina Farias-Eisner et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Predictive power of sexual hormones and tumor markers in endometrial cancer
Mine Kanat-Pektas et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study
Hee Seung Kim et al.
GYNECOLOGIC ONCOLOGY (2010)
Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS
Muriel De Bock et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Identification of potential serum markers for endometrial cancer using protein expression profiling
Masashi Takano et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Inflammatory events in endometrial adenocarcinoma
Alison E. Wallace et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Preoperative CA 125 Tumour Marker in Endometrial Cancer: Correlation With Advanced Stage Disease
Alexandra Sebastianelli et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2010)
Biologic markers in endometrial cancer treatment
Ingeborg B. Engelsen et al.
APMIS (2009)
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K. Huhtinen et al.
BRITISH JOURNAL OF CANCER (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
HE4 as a biomarker for ovarian and endometrial cancer management
Jinping Li et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
Sergio Pecorelli
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis
Mariska M. G. Leeflang et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Systematic Reviews of Diagnostic Test Accuracy
Mariska M. G. Leeflang et al.
ANNALS OF INTERNAL MEDICINE (2008)
Metabolomics-based methods for early disease diagnostics
G. A. Nagana Gowda et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
The role of vaginal hysterectomy in the treatment of endometrial cancer
Susan M. Smith et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Omission of lymphadenectomy is possible for low-risk corpus cancer
T. Hidaka et al.
EJSO (2007)
Endometrial cancer - Revisiting the importance of pelvic and para aortic lymph nodes
Jan G. Aalders et al.
GYNECOLOGIC ONCOLOGY (2007)
Molecular and pathologic aspects of endometrial carcinogenesis
Jonathan L. Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Asne R. Bauskin et al.
CANCER RESEARCH (2006)
Molecular pathogenesis and prognostic factors in endometrial carcinoma
HB Salvesen et al.
APMIS (2002)
What makes a good case-control study? Design issues for complex traits such as endometriosis
KT Zondervan et al.
HUMAN REPRODUCTION (2002)